BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 25008979)

  • 1. Poor emotional well-being is associated with rapid progression in amyotrophic lateral sclerosis.
    Prell T; Steinbach R; Witte OW; Grosskreutz J
    eNeurologicalSci; 2019 Sep; 16():100198. PubMed ID: 31384673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive impairment, behavioral impairment, depression, and wish to die in an ALS cohort.
    Rabkin J; Goetz R; Murphy JM; Factor-Litvak P; Mitsumoto H;
    Neurology; 2016 Sep; 87(13):1320-8. PubMed ID: 27496520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality of life across disease stages in patients with amyotrophic lateral sclerosis: results from a real-world survey.
    Stenson K; Fecteau TE; O'Callaghan L; Bryden P; Mellor J; Wright J; Earl L; Thomas O; Iqbal H; Barlow S; Parvanta S
    J Neurol; 2024 May; 271(5):2390-2404. PubMed ID: 38200398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Covid-19 threat and coping: application of protection motivation theory to the pandemic experiences of people affected by amyotrophic lateral sclerosis.
    Genuis SK; Luth W; Bubela T; Johnston WS
    BMC Neurol; 2022 Apr; 22(1):140. PubMed ID: 35413805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pain-Related Coping Behavior in ALS: The Interplay between Maladaptive Coping, the Patient's Affective State and Pain.
    Schlichte I; Petri S; Dengler R; Meyer T; Haghikia A; Vielhaber S; Vogt S
    J Clin Med; 2022 Feb; 11(4):. PubMed ID: 35207215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling disease course in amyotrophic lateral Sclerosis: pseudo-longitudinal insights from cross-sectional health-related quality of life data.
    Prell T; Gaur N; Steinbach R; Witte OW; Grosskreutz J
    Health Qual Life Outcomes; 2020 May; 18(1):117. PubMed ID: 32357946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative assessment and monitoring of deterioration of articulatory organs using subjective and objective tools among patients with amyotrophic lateral sclerosis.
    Pawlukowska W; Baumert B; Gołąb-Janowska M; Meller A; Machowska-Sempruch K; Wełnicka A; Paczkowska E; Rotter I; Machaliński B; Nowacki P
    BMC Neurol; 2019 Oct; 19(1):241. PubMed ID: 31629403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum Toxin Type A and Physiotherapy in Spasticity of the Lower Limbs Due to Amyotrophic Lateral Sclerosis.
    Marvulli R; Megna M; Citraro A; Vacca E; Napolitano M; Gallo G; Fiore P; Ianieri G
    Toxins (Basel); 2019 Jul; 11(7):. PubMed ID: 31266172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Dyspnea-ALS-Scale (DALS-15) optimizes individual treatment in patients with amyotrophic lateral sclerosis (ALS) suffering from dyspnea.
    Vogt S; Schreiber S; Heinze HJ; Dengler R; Petri S; Vielhaber S
    Health Qual Life Outcomes; 2019 Jun; 17(1):95. PubMed ID: 31159830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spanish adaptation of the Amyotrophic Lateral Sclerosis Questionnaire ALSAQ-40 for ALS patients.
    Salas T; Mora J; Esteban J; Rodríguez F; Díaz-Lobato S; Fajardo M
    Amyotroph Lateral Scler; 2008 Jun; 9(3):168-72. PubMed ID: 18574761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Validity and clinical applicability of the Japanese version of amyotrophic lateral sclerosis--assessment questionnaire 40 (ALSAQ-40)].
    Yamaguchi T; Ohbu S; Saito M; Ito Y; Moriwaka F; Tashiro K; Ohashi Y; Fukuhara S
    No To Shinkei; 2004 Jun; 56(6):483-94. PubMed ID: 15328837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cortisol awakening response in amyotrophic lateral sclerosis is blunted and correlates with clinical status and depressive mood.
    Roozendaal B; Kim S; Wolf OT; Kim MS; Sung KK; Lee S
    Psychoneuroendocrinology; 2012 Jan; 37(1):20-6. PubMed ID: 21616601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Emotions and amyotrophic lateral sclerosis: a psychopathological perspective].
    Bungener C
    Geriatr Psychol Neuropsychiatr Vieil; 2012 Mar; 10(1):57-64. PubMed ID: 22414400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Handicap and quality of life evaluation in amyotrophic lateral sclerosis].
    Sancho PO; Boisson D
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S205-4S207. PubMed ID: 17128112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of physical impairment on emotional well-being in ALS.
    Abdulla S; Vielhaber S; Kollewe K; Machts J; Heinze HJ; Dengler R; Petri S
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Sep; 15(5-6):392-7. PubMed ID: 25008979
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.